News >

Rapid Advances Underscore Significance of Patient Selection in Metastatic Prostate Cancer

Caroline Seymour
Published: Thursday, May 09, 2019

Atish D. Choudhury, MD, PhD

Atish D. Choudhury, MD, PhD

Mature data from several phase III trials, aside from confirming a survival benefit with docetaxel, androgen receptor (AR)-targeted therapy, and radiation therapy in patients with metastatic prostate cancer, underscore the importance of stratifying patients by volume of disease, said Atish D. Choudhury, MD, PhD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 3rd Annual International Congress on Oncology & Pathology™Aug 30, 20201.5
Community Practice Connections™: ASCO Direct™ Highlights – 2019 Official Annual Meeting ReviewAug 30, 20201.5
Publication Bottom Border
Border Publication
x